論文

国際誌
2022年7月

Brachytherapy for primary nasal vestibule cancer using Au-198 grains.

International cancer conference journal
  • Hinako Harada
  • ,
  • Yojiro Ishikawa
  • ,
  • Shohei Tanaka
  • ,
  • Keita Kishida
  • ,
  • Rei Umezawa
  • ,
  • Takaya Yamamoto
  • ,
  • Noriyoshi Takahashi
  • ,
  • Kazuya Takeda
  • ,
  • Yu Suzuki
  • ,
  • Keiichi Jingu

11
3
開始ページ
184
終了ページ
187
記述言語
英語
掲載種別
DOI
10.1007/s13691-022-00546-x

Radiation therapy (RT) is one of the definitive treatments for early-stage nasal vestibular carcinoma and has similar local control rates to resection surgery. There are various methods, including external beam RT and brachytherapy. This report describes a case who showed local control for more than 5 years after brachytherapy alone using Au-198 grains for nasal vestibular carcinoma. A 68-year-old Japanese man complained of swelling and pain in his left nasal cavity. He was diagnosed with squamous cell carcinoma (SCC) (cT1N0M0, stage I). An elevated mass of 8 mm in long diameter was found inside the left nasal cavity. Since the patient selected brachytherapy, nine Au-198 grains 185 mBq were permanently injected percutaneously under local anesthesia, and 85 Gy was prescribed. Grade three dermatitis was observed as an acute adverse event. After 2 years, mild telangiectasia of the left nasal skin and epilation of nasal hair in the left nasal cavity was regarded as late adverse events. The patient continues to keep a complete response for 5 years. For small nasal vestibular SCC, brachytherapy with Au-198 grains might be a good option.

リンク情報
DOI
https://doi.org/10.1007/s13691-022-00546-x
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/35669907
PubMed Central
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163247
ID情報
  • DOI : 10.1007/s13691-022-00546-x
  • PubMed ID : 35669907
  • PubMed Central 記事ID : PMC9163247

エクスポート
BibTeX RIS